肿瘤防治研究2024，Vol.51Issue(4)：234-239,6.DOI:10.3971/j.issn.1000-8578.2024.23.1257
胃癌靶向及免疫治疗进展
Progress of Targeted Therapy and Immunotherapy for Gastric Cancer
郑宇 1潘宏铭1
作者信息
- 1. 310063 杭州,浙江大学医学院附属邵逸夫医院肿瘤内科
- 折叠
摘要
Abstract
Gastric cancer(GC)is a common malignant tumor of the digestive tract in China.It is characterized by high morbidity,mortality,and proportion of patients in advanced stages.In the past years,chemotherapy was used as the main treatment for GC.Subsequently,targeted therapy with trastuzumab was approved to treat HER2-positive GC.However,the progress of drug development and clinical studies has been limited by the high heterogeneity of GC.In recent years,research on immunotherapy and new targets for therapeutic exploration in GC has made great strides.Herein,we provide a brief review of the progress of the research on targeted therapy and immunotherapy for GC.关键词
胃癌/靶向治疗/免疫治疗Key words
Gastric cancer/Targeted therapy/Immunotherapy分类
医药卫生引用本文复制引用
郑宇,潘宏铭..胃癌靶向及免疫治疗进展[J].肿瘤防治研究,2024,51(4):234-239,6.
